Ankang Li, based in Shanghai, Shanghai, China, is currently a Chief Financial and Strategy Officer at Brii Biosciences, bringing experience from previous roles at Brii Biosciences, Terns Pharmaceuticals, Goldman Sachs and MSD. Ankang Li holds a 2009 - 2012 Doctor of Jurisprudence in Law @ University of Chicago Law School. With a robust skill set that includes Capital Markets, Corporate Law, Mergers & Acquisitions, Corporate Governance, Mergers and more, Ankang Li contributes valuable insights to the industry. Ankang Li has 5 emails and 1 mobile phone number on RocketReach.